Often, the most groundbreaking commercial ideas do not emerge from corporate boardrooms or extensive market research, but rather from personal adversity. The journey of Agatsa Software, which has now grown into a business valued at 105 crore rupees, began precisely from a pressing health issue faced within a family home.
Finding a Solution to a Domestic Challenge
The enterprise was co-founded by Neha Rastogi alongside her husband Rahul Rastogi. The catalyst for the venture occurred when Neha's father-in-law suffered a heart attack, leading to a situation where he had to make frequent, exhausting trips to the hospital for routine checkups. Seeking to eliminate the relentless hospital visits, the couple conceptualized a solution that would allow an electrocardiogram to be performed right at home. Their core vision was to shrink bulky hospital ECG machinery down to the size of a standard keychain, making cardiovascular monitoring accessible anywhere.
The Birth of the Portable ECG Device
To realize this vision, Neha and her husband engineered a portable ECG device named SanketLife. Unlike traditional diagnostic equipment, this device operated entirely without conventional ECG wires and electrodes, capturing readings directly from the body and displaying the data seamlessly on a smartphone. The invention gained significant traction in the market because it effectively removed the logistical burden of regular monitoring for heart patients.
Technical Background and Development Timeline
Both founders brought strong technical backgrounds to the venture, as Neha possessed deep expertise in software development while Rahul was skilled in electronics. Although they were previously employed at separate companies, witnessing their family's struggle prompted them to pool their skills and dedicate themselves fully to the project. They consulted numerous medical professionals and refined their concept into a working prototype. Development officially commenced in 2010, and the device was successfully introduced to the commercial market in 2017. The apparatus featured specialized sensors to capture readings through the fingertips and interface directly with mobile applications.
Funding Milestones and Corporate Backing
Once the prototype was finalized, manufacturing required substantial financial backing. The Technology Development Board, a government institution, stepped in with funding of 3.91 crore rupees, enabling commercial production to begin. In August 2023, the firm secured Series A funding, which propelled its valuation to 105 crore rupees. Major pharmaceutical enterprise Sun Pharma invested 30 crore rupees into the company, acquiring a stake exceeding 26 percent. During the 2024-25 fiscal year, the company recorded a revenue of approximately 1 crore rupees.



















